What You Should Know:
- Solace, a digital health platform connecting patients with expert healthcare advocates secures $14M in Series A funding led by Inspired Capital, with participation from existing backers Craft Ventures and Torch Capital, as well as new investors including Anne Wojcicki, the late Susan Wojcicki, RiverPark Ventures, and Coalition Operators.
- The new funding brings Solace's total funding to $21M since its founding.
Empower Patients through
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Jumo Health Secures Funding to Improve Clinical Trial Enrollment
What You Should Know:
- Falfurrias Management Partners (Falfurrias), a Charlotte-based private equity firm focused on growth-oriented, middle-market businesses, today announced its investment in Jumo Health, an innovative and award-winning clinical trial solutions company driving better outcomes for clinical trials globally.
- Jumo Health develops creative, patient-centric educational solutions that improve health literacy to accelerate clinical trial enrollment and increase participant
Read More
Openwater Secures $100M to Tackle Diseases at the Cellular Level
What You Should Know:
- Openwater, a pioneering healthcare technology company, today announced the acceleration of its plans to commercialize its groundbreaking platform that leverages semiconductor physics, light, and sound to diagnose and treat diseases at the cellular level.
- Founded by Mary Lou Jepsen, a former executive at Google X, Meta, and "One Laptop Per Child," Openwater has secured $100M in funding to advance its mission of making advanced medical care accessible
Read More
CancerIQ Raises Growth Capital for Personalized Cancer Detection
What You Should Know:
- CancerIQ, a Chicago, IL-based precision health platform focused on empowering healthcare providers to personalize cancer prevention and early detection announced it has secured a growth funding package from Decathlon Capital Partners.
- While specific financial details of the transaction were not disclosed, the investment will enable CancerIQ to further develop its digital tools, introduce new offerings, and strengthen partnerships with healthcare
Read More
PreciseDx Raises $20.7M for AI-Powered Cancer Risk Assessments
What You Should Know:
- PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide Asset Management with participation from Labcorp, Quest Diagnostics, GenHenn Capital Venture, and existing investors. This brings the company's total funding to date to $31.5M.
- The new funding will enable PreciseDx to accelerate its growth and expand its operations. The company plans to invest in talent
Read More
Piramidal Secures $6M to Expand Foundational AI Brain Model for Neurologists
What You Should Know:
- Upstart technology innovator Piramidal has secured $6 million in seed funding to aid its development of a barrier-breaking artificial intelligence (AI) model that will help neurologists assess brainwave data, with the potential to democratize analysis and shorten patient waiting time.
- The seed funding round attracted high-profile investors, including Y Combinator, Adverb Ventures, Lionheart Ventures, and angel investors such as founders of Intercom, Plangrid,
Read More
Clarium Secures $10.5M for AI-Powered Hospital Supply Chain
What You Should Know:
- Clarium, Inc., a healthcare technology innovator focused on transforming hospital supply chain operations, has secured a $10.5M in strategic financing round led by General Catalyst, with participation from Kaiser Permanente Ventures, Texas Medical Center Venture Fund, Yale New Haven Health, and existing investors.
- With this new funding, Clarium plans to expand its team, deepen partnerships with leading health systems, and continue refining its
Read More
Reliant AI Emerges from Stealth with $11.3M for GenAI Biopharma Data Analysis
What You Should Know:
- Reliant AI, a provider of generative AI-powered data analytics software, today announced its official launch and a significant $11.3M in seed funding round led by Tola Capital and Inovia Capital, with participation from angel investor Mike Volpi, the investment will fuel the company's growth and expansion.
- Founded by a team of leading experts in natural language processing and reinforcement learning with backgrounds at DeepMind, Google Brain, and EY
Read More
Accenture Invests in Earli Inc. for Early Cancer Detection
What You Should Know:
- Accenture today announced a strategic investment in Earli Inc., a biotechnology company pioneering a novel approach to early cancer detection.
- Earli’s groundbreaking technology aims to transform cancer diagnosis and treatment by enabling the rapid and accurate identification of cancerous cells.
Synthetic Targeting Platform for Early Cancer Detection
Earli has developed a synthetic targeting platform that selectively reprograms cancer cells,
Read More
Caresyntax Secures $180M to Advance Precision Surgery Platform
What You Should Know:
- Caresyntax, a leader in vendor-neutral precision surgery platforms raises $180M in funding, comprised of $80M in equity and up to $100M in growth debt, will fuel the company's continued growth and development of its AI-powered surgical platform.
- The funding round was led by a consortium of prominent investors, including Symbiotic Capital, MTIP AG, BIONIQ Capital, and BlackRock Innovation Capital. This significant investment demonstrates the growing
Read More
